Calcyphosine 2 antibody (AA 221-320) (AbBy Fluor® 680)

Catalog No. ABIN4998941

This anti-Calcyphosine 2 antibody is a Rabbit Polyclonal antibody detecting Calcyphosine 2 in IF (cc) and IF (p). Suitable for Human.

Quick Overview for Calcyphosine 2 antibody (AA 221-320) (AbBy Fluor® 680) (ABIN4998941)

Target: Calcyphosine 2 (CAPS2)

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Calcyphosine 2 antibody is conjugated to AbBy Fluor® 680

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Product Details anti-Calcyphosine 2 Antibody (AbBy Fluor® 680)

Binding Specificity: AA 221-320

Predicted Reactivity: Human,Mouse,Rat,Cow,Sheep,Pig,Chicken

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Calcyphosine 2/CAPS2

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for Calcyphosine 2

Target: Calcyphosine 2 (CAPS2)

Alternative Name: Calcyphosine 2/CAPS2

Background:

Synonyms: Calcyphosin 2, Calcyphosin-2, Calcyphosine-2, Calcyphosine2, Calcyphosphine 2, CAPS 2, CAPS2, CAYP2_HUMAN, D630005B03Rik, FLJ34520, OTTHUMP00000202412, OTTMUSP00000027695, UG0636c06.

Background: CAPS2 is a 557 amino acid calcium-binding protein that is abundantly expressed, with highest expression found in placenta, testis, colon, lung and brain. CAPS2 contains three EF-hand domains and exists as three alternatively spliced isoforms. Suggested to play a role in large dense-core vesicle (LDCV) exocytosis, CAPS2 is encoded by a gene that maps to human chromosome 12, which encodes over 1,100 genes and comprises approximately 4.5 % of the human genome. Chromosome 12 is associated with a variety of diseases and afflictions, including hypochondrogenesis, achondrogenesis, Kniest dysplasia, Noonan syndrome and trisomy 12p, which causes facial developmental defects and seizure disorders.